Ftse Mib
34.430,69
-0,50%
DAX
18.673,54
-0,28%
S&P 500
5.320,45
-0,02%
NASDAQ
16.843,92
0,07%
Bitcoin
70.103,21
-0,04%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Neurobiological Technologies (MM) (NTII) Neurobiological Technologies (MM) (NTII) Notizie

NTII

Neurobiological (NTII)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NTII
DataOraFonteTitoloSimboloCompagnia
07/12/200920:18Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NTIINeurobiological Technologies (MM)
07/12/200919:41Edgar (US Regulatory)-National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25)NASDAQ:NTIINeurobiological Technologies (MM)
23/11/200914:00PR Newswire (US)Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per ShareNASDAQ:NTII
16/11/200919:43Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:NTIINeurobiological Technologies (MM)
09/11/200922:30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTIINeurobiological Technologies (MM)
28/10/200914:00PR Newswire (US)Neurobiological Technologies Announces Stockholder Approval of Plan of Liquidation and DissolutionNASDAQ:NTII
26/10/200919:00Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NTIINeurobiological Technologies (MM)
26/10/200918:59Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:NTIINeurobiological Technologies (MM)
23/10/200923:19Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:NTIINeurobiological Technologies (MM)
19/10/200922:20PR Newswire (US)Neurobiological Technologies Announces Intent to File Form 25 to Delist Common Stock From the NASDAQ Capital MarketNASDAQ:NTII
22/09/200912:01Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:NTIINeurobiological Technologies (MM)
17/09/200923:00PR Newswire (US)Neurobiological Technologies Receives Nasdaq Closing Bid Price NotificationNASDAQ:NTII
08/09/200922:28Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:NTIINeurobiological Technologies (MM)
31/08/200922:27PR Newswire (US)Neurobiological Technologies Announces Board Approval of Plan of Liquidation and DissolutionNASDAQ:NTIINeurobiological Technologies (MM)
31/08/200922:14Edgar (US Regulatory)Annual Report (10-K)NASDAQ:NTIINeurobiological Technologies (MM)
12/08/200914:30PR Newswire (US)Neurobiological Technologies Announces Termination of its License and Cooperation Agreement with Merz and Children's Medical CenNASDAQ:NTIINeurobiological Technologies (MM)
01/06/200914:30PR Newswire (US)Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical ProgramNASDAQ:NTIINeurobiological Technologies (MM)
08/05/200913:00PR Newswire (US)Neurobiological Technologies Reports Third Quarter Fiscal 2009 Financial ResultsNASDAQ:NTIINeurobiological Technologies (MM)
01/05/200913:00PR Newswire (US)Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of MemantineNASDAQ:NTIINeurobiological Technologies (MM)
26/03/200912:30PR Newswire (US)Neurobiological Technologies Announces Hiring of Advisor to Seek Sale of CompanyNASDAQ:NTIINeurobiological Technologies (MM)
18/02/200912:02Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:NTIINeurobiological Technologies (MM)
12/02/200922:30PR Newswire (US)Neurobiological Technologies Reports Second Quarter Fiscal 2009 Financial ResultsNASDAQ:NTIINeurobiological Technologies (MM)
05/02/200922:17Edgar (US Regulatory)Amended Current report filing (8-K/A)NASDAQ:NTIINeurobiological Technologies (MM)
04/02/200913:00PR Newswire (US)Neurobiological Technologies Announces Appointment of William A. Fletcher as Acting CEONASDAQ:NTIINeurobiological Technologies (MM)
23/01/200912:02Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:NTIINeurobiological Technologies (MM)
13/01/200913:30PR Newswire (US)Neurobiological Technologies Announces Suspension of Viprinex DevelopmentNASDAQ:NTIINeurobiological Technologies (MM)
17/12/200813:00PR Newswire (US)Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility AnalysisNASDAQ:NTIINeurobiological Technologies (MM)
16/12/200814:00PR Newswire (US)Neurobiological Technologies' Partner, Celtic Pharma, Provides Update on XERECEPT(R) Clinical Program and Planned Sale in 2009NASDAQ:NTIINeurobiological Technologies (MM)
06/11/200812:30PR Newswire (US)Neurobiological Technologies, Inc. Reports First Quarter Fiscal Year 2009 Financial ResultsNASDAQ:NTIINeurobiological Technologies (MM)
05/11/200822:08Edgar (US Regulatory)Amended Securities Registration (section 12(g)) (8-A12G/A)NASDAQ:NTIINeurobiological Technologies (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NTII

La tua Cronologia

BIT
UCG
Unicredit
BIT
STMMI
ST Microelectronics
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
SPM
Saipem
BIT
TIT
Telecom Italia
BIT
TEN
Tenaris
BIT
LDO
Leonardo
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
G
Generali
BIT
SRG
Snam
BIT
BAMI
Banco BPM
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network